A detailed history of Tortoise Investment Management, LLC transactions in Danaher Corp stock. As of the latest transaction made, Tortoise Investment Management, LLC holds 164 shares of DHR stock, worth $44,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares
164
Previous 152 7.89%
Holding current value
$44,366
Previous $37,000 8.11%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$235.51 - $267.98 $2,826 - $3,215
12 Added 7.89%
164 $40,000
Q1 2024

May 09, 2024

BUY
$224.58 - $256.19 $4,491 - $5,123
20 Added 15.15%
152 $37,000
Q4 2023

Feb 08, 2024

SELL
$185.1 - $233.13 $1,480 - $1,865
-8 Reduced 5.71%
132 $30,000
Q3 2023

Nov 09, 2023

BUY
$233.08 - $265.59 $1,165 - $1,327
5 Added 3.7%
140 $34,000
Q4 2022

Feb 03, 2023

BUY
$241.42 - $282.29 $3,379 - $3,952
14 Added 11.57%
135 $35,000
Q3 2022

Nov 04, 2022

SELL
$247.06 - $1507.4 $4,200 - $25,625
-17 Reduced 12.32%
121 $31,000
Q2 2022

Aug 03, 2022

BUY
$237.11 - $299.66 $18,494 - $23,373
78 Added 130.0%
138 $35,000
Q2 2021

Jul 30, 2021

BUY
$225.08 - $271.69 $2,250 - $2,716
10 Added 20.0%
60 $16,000
Q1 2021

May 05, 2021

BUY
$212.38 - $245.9 $10,619 - $12,295
50 New
50 $11,000
Q1 2020

May 05, 2020

SELL
$121.39 - $169.05 $58,267 - $81,144
-480 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$133.47 - $153.48 $57,792 - $66,456
433 Added 921.28%
480 $74,000
Q3 2019

Nov 06, 2019

SELL
$135.4 - $146.47 $64,992 - $70,305
-480 Reduced 91.08%
47 $7,000
Q4 2018

Feb 08, 2019

SELL
$94.85 - $109.54 $4,552 - $5,257
-48 Reduced 8.35%
527 $54,000
Q4 2017

Jan 31, 2018

BUY
$85.26 - $94.62 $4,007 - $4,447
47 Added 8.9%
575 $53,000
Q3 2017

Nov 15, 2017

BUY
$79.29 - $88.45 $41,865 - $46,701
528
528 $45,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $197B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Tortoise Investment Management, LLC Portfolio

Follow Tortoise Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tortoise Investment Management, LLC with notifications on news.